| # | Drug | Count |
|---|---|---|
| 0 | INCLISIRAN | 12 |
| 1 | EZETIMIBE | 2 |
| 2 | DAPAGLIFLOZIN | 1 |
| 3 | METFORMIN | 1 |
| 4 | METFORMIN ER 500 MG | 1 |
| 5 | METFORMIN ER 750 MG | 1 |
| 6 | OMALIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INCLISIRAN | 12 | 0.0014 |
| 1 | EZETIMIBE | 2 | 0.0000 |
| 2 | DAPAGLIFLOZIN | 1 | 0.0000 |
| 3 | OMALIZUMAB | 1 | 0.0000 |
| 4 | METFORMIN ER 500 MG | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Dietary Cholesterol Absorption Inhibitor [EPC] | 2 |
| 1 | Anti-IgE [EPC] | 1 |
| 2 | PCSK9 Inhibitor [EPC] | 1 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Dietary Cholesterol Absorption Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Anti-IgE [EPC] | 1 | 0.0000 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |